Wealth Enhancement Advisory Services’s Virtus Biotech ETF BBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$11.8M Buy
116,551
+12,177
+12% +$1.24M 0.02% 660
2026
Q2
$10.5M Buy
+104,374
New +$9.08M 0.02% 654
2025
Q4
– Sell
-5,070
Closed -$363K – 3667
2025
Q3
$363K Hold
5,070
– – ﹤0.01% 2624
2025
Q2
$303K Buy
+5,070
New +$287K ﹤0.01% 2635

Other funds holding BBP

Wealth Enhancement Advisory Services's BBP Position: Q3 2026 in Review

Wealth Enhancement Advisory Services increased its Virtus Biotech ETF (BBP) stake by 12% in Q3 2026, buying an estimated $1.24M and bringing the position to 116,551 shares worth $11.8M. The position accounts for 0.02% of the portfolio, ranked #660.

Wealth Enhancement Advisory Services first reported a position in BBP in Q2 2025 and has held it in 4 quarters since. 33 funds tracked by Wall St. Rank hold BBP as of Q3 2026.

  • Wealth Enhancement Advisory Services held 116,551 shares of Virtus Biotech ETF worth $11.8M as of Q3 2026.
  • Wealth Enhancement Advisory Services bought 12,177 Virtus Biotech ETF shares in Q3 2026, an estimated $1.24M.
  • Virtus Biotech ETF made up 0.02% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #660 holding.
  • Wealth Enhancement Advisory Services first reported a position in Virtus Biotech ETF in Q2 2025 and has held it in 4 quarters since.
  • 33 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.